Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique

Bechgaard H, Nielsen GH (1978) Controlled-release multiple-units and single-unit doses a literature review. Drug Dev Ind Pharm 4:53–67

Broadbent AL, Fell RJ, Codd SL, Lightley KA, Konagurthu S, Koehler-King DG et al (2010) Magnetic resonance imaging and relaxometry to study water transport mechanisms in a commercially available gastrointestinal therapeutic system (GITS) tablet. Int J Pharm 397:1–2

Chung M, Reitberg DP, Gaffney M, Singleton W (1987) Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system: a controlled-release formulation of nifedipine. Am J Med 83(6):10–14

Dey NS, Majumdar S, Rao MEB (2008) Multiparticulate Drug Delivery Systems for Controlled Release. Trop J Pharm Res 7(3):1067

Dukic A, Mens R, Adriaensens P, Foreman P, Gelan J, Remon JP et al (2007) Development of starch-based pellets via extrusion/spheronisation. Eur J Pharm Biopharm 66(1):83–94

Elliott HL, Meredith PA, Vincent J, Reid JL (1986) Clinical pharmacological studies with doxazosin. Br J Clin Pharmacol 21(Suppl 1):27S

El-Massik M (2007) Preparation and evaluation of extended release doxazosin lipid matrix granules. Alex J Sci 21:111–117

Fawzy A, Vashi V, Chung M, Dias N, Gaffney M (1999) Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia* 1. Urology 53(2):329–335

FDA Guidelines for dissolution of drugs. http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm . Accessed 12 Oct 2012

Harris MR, Ghebre-Sellassie I (1989) Formulation variables. Pharmaceutical Pelletization Technology. Marcel Dekker Inc, New York, pp 217–239

Harris, Ghebre-Sellassie I (2008) Aqueous polymeric coating for modified release oral dosage forms. Aqueous Polymer Coat Pharm Dosage Forms 47:103–113

Hazzah H, El-Massik MA, Abdallah OY (2010) Physical characterization of imported and locally made placebo pellets. Alex J Pharm Sci 24:90–97

Hernandez C, Duran R, Jara J, Castano I, Moralejo M (2005) Controlled-release doxazosin in the treatment of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 8(4):375

Hwang SJ, Park H, Park K (1998) Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst 15(3):243–284

Iyer U, Hong WH, Das N, Ghebre-Sellassie I (1990) Comparative evaluation of three organic solvent and dispersion-based ethylcellulose coating formulations. Pharm Technol 14(9):68–86

Jagan Mohan Kandukuri VA, Chandra Mohan Eaga, Vasu Keshetty, Kiran Kumar Jannu (2009) Pelletization techniques for oral drug delivery. Int J Pharm Sci Drug Res 1(2):63–70

Jones DM (1989) Solution and suspension layering. In: Ghebre-Sellassie (ed) Pharmaceutical pelletization technology. Marcel Dekker, New York, pp 145–164

Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT (2008) Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling. Eur J Pharm Biopharm 70(1):289–301

Lopes CM, Lobo JMS, Pinto JF, Costa P (2006) Compressed mini-tablets as a biphasic delivery system. Int J Pharm 323(1–2):93–100

Muschert S, Siepmann F, Leclercq B, Carlin B, Siepmann J (2009) Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Eur J Pharm Biopharm 72(1):130–137

Pavli M, Vrecer F, Baumgartner S (2010) Matrix tablets based on carrageenans with dual controlled release of doxazosin mesylate. Int J Pharm 400:15–23

Riess JG, Swarbrick J (2007) Encyclopedia of pharmaceutical technology. Marcel Dekker, New York

Roy P, Shahiwala A (2009) Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release 134:74–80

Shaji J, Chadawar V, Talwalkar P (2007) Multiparticulate drug delivery system. Indian Pharm 6:21–28

Skalsky B, Petereit HU (2008) Chemistry and application properties of polymethacrylate systems. Aqueous Polymer Coat Pharm Dosage Forms 42:237

Sun GH, Tsui KH, Wu TT, Chang CH, Cheng CL, Schou M (2006) Efficacy and Safety of the Doxazosin Gastrointestinal Therapeutic System for the Treatment of Benign Prostate Hyperplasia. Kaohsiung J Med Sci 26(10):532–539

Trivedi NR, Rajan M, Johnson JR, Shukla AJ (2007) Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit Rev Ther Drug Carrier Syst 24(1):1–40